Option chain shows key data for enGene Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for enGene Holdings.

enGene Holdings (NASDAQ:ENGN) Stock, Option Chain

enGene Holdings

iShares Industrial Bond ETF

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

4 Stocks You Need To Buy Now for Consistent Profits—Here’s Why Analysts Love Them

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ATYR

ENGN

ESLA

SHLS

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Stock market analysts

ALAB

INGM

KRRO

This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

vaccine-4892048

enGene shares are trading higher by 6.7% during Friday&#39;s session. The company announced it generated approximately $60 million in proceeds from a private placement.

Why enGene Holdings Stock Is Trading Higher

enGene Holdings Inc

Press Releases

enGene Announces $60 Million Private Placement Financing

enGene to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

enGene to Participate in Upcoming Investor Conferences

enGene Reports Full Year 2024 Financial Results and Provides a Business Update

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)

enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

enGene to Participate in the Leerink Partners Global Healthcare Conference

enGene Reports First Quarter 2025 Financial Results and Provides Business Update

Morgan Stanley

HC Wainwright & Co.

Piper Sandler

JMP Securities

Comments

enGene Holdings

enGene Holdings (ENGN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga